Local

Trials show COVID-19 vaccine for young kids works

Modern says 2/3 phase trials of COVID-19 vaccines for infants and young children show that shooting works.

In a press release Tuesday, the company said low-dose formulas – one for six-month-olds and one for 2- to 6-year-olds – showed a “strong neutralizing antibody response” along with a “favorable safety profile”. . “

The company added that it will soon submit its emergency permit to the Food and Drug Administration.

“Given the need for a vaccine against COVID-19 in infants and young children, we are working with the US FDA and global regulators to send this data as soon as possible,” said Stéphane Bancel, CEO of Modern.

At the moment, children under the age of five are the only people in the United States who are not eligible for the COVID-19 vaccine. according to US Census Bureauwhich represents 6% of the country’s population.

The modern announcement comes as drugmaker Pfizer partner regulators are fighting to approve the COVID-19 vaccine for young children. In February, the FDA He has postponed the meeting of the Advisory Board in which the table was scheduled to discuss whether to accept the plans. While Pfizer’s vaccine may seem safe, the data indicates that it may not work well enough to meet FDA standards.

Pfizer CEO told CBS News earlier this month expects the company to approve the COVID-19 vaccine for children under 5 in May.



Trials show COVID-19 vaccine for young kids works Source link Trials show COVID-19 vaccine for young kids works

Related Articles

Back to top button